Ying Wang

Dr. Ying Wang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
RZRuofei Zhang
Ruofei Zhang
YSYanfang Shen
Yanfang Shen
XZXiaoying Zhou
Xiaoying Zhou
JLJianru Li
Jianru Li
HZHanqing Zhao
Hanqing Zhao
Kelong FanKelong Fan
Kelong Fan
Nasopharyngeal carcinoma (NPC), a malignancy highly prevalent in East and Southeast Asia, is primarily treated with radiotherapy (RT). However, hypoxia-induced radioresistance presents a significant challenge. Nanozymes, nanomaterials with catalase-like activity, have emerged as a promising strategy for radiosensitization by converting elevated hydrogen peroxide in the tumor microenvironment into oxygen. Despite their potential, effectively targeting hypoxic lesions has been difficult. Here, we identify transferrin receptor 1 (TfR1) as an upregulated target in NPC, with its expression levels positively correlated with hypoxia. Human heavy-chain ferritin, a specific ligand of TfR1, selectively recognizes hypoxic NPC lesions in preclinical models. Based on these findings, we design a hypoxia-targeted nanozyme by loading platinum nanoparticles into ferritin. This nanozyme exhibits enhanced catalase-like activity and effectively alleviates tumor hypoxia in NPC xenografts. When combined with RT, a single injection of the nanozyme significantly inhibits tumor growth and prolongs mouse survival, outperforming sodium glycididazole, a clinically used radiosensitizer. In summary, our findings highlight TfR1 as an accessible cell surface target in hypoxic NPC lesions. The nanozyme targeting TfR1 holds promise for enhancing the therapeutic effectiveness of RT in NPC through an in situ oxygen-generation mechanism.

30 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
QHQiyi Hu
Qiyi Hu
GWGuojie Wang
Guojie Wang
XSXiaoyi Song
Xiaoyi Song
JWJingjing Wan
Jingjing Wan
MLMan Li
Man Li
YWYing Wang
Ying Wang
Purpose: This study aimed to explore the predictive efficacy of radiomics analyses based on readout-segmented echo-planar diffusion-weighted imaging (RESOLVE-DWI) for prognosis evaluation in nasopharyngeal carcinoma in order to provide further information for clinical decision making and intervention. Methods: A total of 154 patients with untreated NPC confirmed by pathological examination were enrolled, and the pretreatment magnetic resonance image (MRI)—including diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC) maps, T2-weighted imaging (T2WI), and contrast-enhanced T1-weighted imaging (CE-T1WI)—was collected. The Random Forest (RF) algorithm selected radiomics features and established the machine-learning models. Five models, namely model 1 (DWI + ADC), model 2 (T2WI + CE-T1WI), model 3 (DWI + ADC + T2WI), model 4 (DWI + ADC + CE-T1WI), and model 5 (DWI + ADC + T2WI + CE-T1WI), were constructed. The average area under the curve (AUC) of the validation set was determined in order to compare the predictive efficacy for prognosis evaluation. Results: After adjusting the parameters, the RF machine learning models based on extracted imaging features from different sequence combinations were obtained. The invalidation sets of model 1 (DWI + ADC) yielded the highest average AUC of 0.80 (95% CI: 0.79–0.81). The average AUCs of the model 2, 3, 4, and 5 invalidation sets were 0.72 (95% CI: 0.71–0.74), 0.66 (95% CI: 0.64–0.68), 0.74 (95% CI: 0.73–0.75), and 0.75 (95% CI: 0.74–0.76), respectively. Conclusion: A radiomics model derived from the MRI DWI of patients with nasopharyngeal carcinoma was generated in order to evaluate the risk of recurrence and metastasis. The model based on MRI DWI can provide an alternative approach for survival estimation, and can reveal more information for clinical decision-making and intervention.

21 February 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
YSYanfang Shen
Yanfang Shen
RZRuofei Zhang
Ruofei Zhang
YWYing Wang
Ying Wang
A facile method for the synthesis of metal-doped carbon dot (CD) nanozymes using ferritin nanocages as precursors is presented.

30 June 2022 in Molecular Imaging
Verified
Journal Article
Open access
PDF file
WLWeize Lv
Weize Lv
MYMin Yang
Min Yang
HZHongcheng Zhong
Hongcheng Zhong
XWXiaojin Wang
Xiaojin Wang
SYShuai Yang
Shuai Yang
HSHong Shan
Hong Shan
It has been a big challenge to distinguish synchronous multiple primary lung cancer (sMPLC) from primary lung cancer with intrapulmonary metastases (IPM). We aimed to assess the clinical application of dynamic 18F-FDG PET/CT in patients with multiple lung cancer nodules. We enrolled patients with multiple pulmonary nodules who had undergone dynamic 18F-FDG PET/CT and divided them into sMPLC and IPM groups based on comprehensive features. The SUVmax, fitted [ ] value based on dynamic scanning, and corresponding maximum diameter ([ ]) from the two largest tumors were determined in each patient. We determined the absolute between-tumor difference of [ ] and [ ] ([ ]; [ ]) and assessed the between-group differences. Further, the diagnostic accuracy was evaluated by ROC analysis and the correlation between [ ] and [ ] from all groups was determined. There was no significant difference for [ ] between the IPM and sMPLC groups, while the IPM group had a significantly higher [ ] than the sMPLC group. The AUC of [ ] for differentiating sMPLC from IPM was 0.80 (cut-off value of [ ], sensitivity 79%, specificity 75%, [ ]). There was a good correlation (Pearson [ ], 95% CI: 0.79-0.96, [ ]) between [ ] and [ ] in the IPM group but not in the sMPLC group (Pearson [ ], [ ]). Dynamic 18F-FDG PET/CT could be a useful tool for distinguishing sMPLC from IPM. [ ] calculation based on Patlak graphic analysis could be more sensitive than SUVmax in discriminating IPM from sMPLC in patients with multiple lung cancer nodules.

12 January 2024 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
XSXiaoyi Song
Xiaoyi Song
XDXiaobei Duan
Xiaobei Duan
XHXinghua He
Xinghua He
YWYubo Wang
Yubo Wang
KLKunwei Li
Kunwei Li
HSHong Shan
Hong Shan

25 October 2025 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
QHQianyi Huang
Qianyi Huang
JMJunjian Mo
Junjian Mo
XDXuanbang Deng
Xuanbang Deng
YJYongluo Jiang
Yongluo Jiang
MYMin Yang
Min Yang
YWYing Wang
Ying Wang